Improve gait and balance remotely
- Trial ID
- NCT06052280
- Official Title
- Management of Initial Parkinson's Disease: a Prospective, Mono-centric, no Profit Pilot Clinical Trial Comparing Conventional Face-to-face Physiotherapy and Home-based Telerehabilitation
- Goal
- Improve gait and balance remotely
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Azienda Sanitaria Locale CN1 Cuneo
- Study Type
- INTERVENTIONAL
- Enrollment
- 40 participants
- Conditions
- Parkinson Disease
- Interventions
- Telerehabilitation exercise program, Home self-exercise program
Plain-Language Summary
The goal is to see if home-based, therapist-led telerehabilitation can match or improve early Parkinson's management for mobility, balance and daily function compared with conventional physiotherapy or a self-directed home program. The telerehab arm delivers live, video-guided exercise sessions with real-time feedback and progression from a physiotherapist, while the home arm follows a prescribed self-exercise plan; both focus on strength, gait and balance and are meant to complement, not replace, medications like levodopa by helping you move better on your current drug regimen. The trial is looking for adults 18 and older with idiopathic Parkinson's at early stages (Hoehn and Yahr stage 2 or below), a MoCA score above 25, ability to consent and participate, and for the telerehab arm reliable home internet and about 2 meters of clear space in front of a device. People with atypical Parkinsonism or serious medical problems that would limit moderate exercise are excluded.
Locations
- Azienda Sanitaria Locale CN1, Cuneo, Italy
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Telerehabilitation exercise program. The goal is to see if home-based, therapist-led telerehabilitation can match or improve early Parkinson's management for mobility, balance and daily function compared with conventional physiotherapy or a self-directed home program. The telerehab arm delivers live, video-guided exercise sessions with real-time feedback and progression from a physiotherapist, while the home arm follows a prescribed self-exercise plan; both focus on strength, gait and balance and are meant to complement, not replace, medications like levodopa by helping you move better on your current drug regimen. The trial is looking for adults 18 and older with idiopathic Parkinson's at early stages (Hoehn and Yahr stage 2 or below), a MoCA score above 25, ability to consent and participate, and for the telerehab arm reliable home internet and about 2 meters of clear space in front of a device. People with atypical Parkinsonism or serious medical problems that would limit moderate exercise are excluded.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year.